The nation of Zimbabwe has turned down a substantial American health deal worth $367m (£272m) over five years over Washington's insistence on sensitive data.
This rejection came to light after a government memo from December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the agreement was "skewed".
An official spokesperson later clarified that the United States was requesting genetic material for research and commercial purposes while was unwilling to share the benefits from future treatments.
"We will now turn to the challenging and unfortunate task of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had donated more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has appealed for further talks to reach a deal acceptable to all parties so the nation's critical HIV programme can proceed.
Wider Background
Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a high court blocked a similar health funding agreement following concerns were filed about the safety of Kenyans' medical information.
Since returning to the presidency last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
The agency had managed aid for the US government, but Trump argued its expenditure was "wasteful" and his administration was pursuing government-to-government agreements to enhance openness and accountability.
According to statements, 16 African countries have to date agreed to these new agreements, representing more than $18.3bn in committed funds.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration might have yielded immense advantages for Zimbabwean communities, particularly the 1.2 million presently receiving HIV treatment through US-supported programmes," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".
"Zimbabwe was being asked to share its genetic material and health information indefinitely, with no corresponding assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.
"In essence, our nation would provide the raw materials for scientific discovery without any assurance that the final treatments would be available to our people if a future disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further noted that the US's withdrawal from the global health body and its pursuit of bilateral deals were upending frameworks already established via the global health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing framework created to manage future pandemics.
"This system is designed to ensure that when a country contributes its information, the benefits – such as medicines and cures – are shared equitably, not commercialised solely by those with the funds to create them."
The government's concerns regarding the US deal "must not be interpreted as opposition to America," he added.
"We encourage further discussions with our American counterparts on how subsequent co-operation could be structured in a manner that respects the sovereignty and dignity of each country."
Health Experts Reaction
A leading public health body stated it acknowledged the official position, but suggested that negotiations should continue given that much of the country's HIV programmes were funded by foreign aid.
"In cases where specific concerns exist, such as those involving information security or implementation frameworks, these can frequently be addressed through technical clarification and mutually agreed protections," the group added.
The halted deal highlights the continuing challenges between accepting vital international aid and safeguarding a country's data in an increasingly interconnected world.